General Biophysics
Xenon Gas Research in Neurodegeneration, OUD & Cell Preservation
Neurodegeneration and Aging
Explore our approach to Alzheimer's disease.
Approximately 30 million people have Alzheimer’s Disease (AD). Unfortunately, there is no cure. We are developing a therapeutic approach to target microglial dysregulation. Our drug-device combination product is based on the proprietary xenon gas mixture delivered to patients through the automatic inhalation system.
Opioid Use Disorder
Promising Treatment for substance use disorder and pain management
Opioid Use Disorder (OUD) affects 4.8 million people in the United States, continuing to devastate lives and communities. Through its xenon inhalation technology, General Biophysics is developing a therapy designed to alleviate opioid withdrawal symptoms and facilitate opioid tapering—translating cutting-edge neuroscience into effective treatment.
Cellular Preservation Technology (CPT)
Discover our advancements in cell preservation.
We are developing innovative solutions to improve the availability of precious biological agents with potent therapeutic applications. Our initial product is a revolutionary platelet storage system which transforms the useful lifespan of platelets from five to fourteen days.
General Biophysics is at the forefront of xenon gas research, focusing on developing innovative therapeutic solutions for some of the most complex medical challenges, including neurodegeneration, opioid use disorder, and cellular preservation.
Our research in neurodegenerative diseases, including Alzheimer’s disease, explores how xenon gas can modulate microglial activity, reduce inflammation, and protect neuronal function. With millions of people affected globally and no definitive cure available, our goal is to develop a novel xenon-based therapeutic approach delivered through advanced inhalation systems.
In the field of opioid use disorder (OUD), we are investigating how xenon inhalation can reduce withdrawal symptoms, support opioid tapering, and offer a safer, non-addictive alternative for pain management. This research addresses a critical public health crisis in the United States, where millions of individuals are impacted by opioid dependence.
Our Cellular Preservation Technology (CPT) initiative focuses on extending the viability of biological materials such as platelets. By increasing platelet storage duration from five to fourteen days, we aim to improve the availability and effectiveness of life-saving treatments.
By combining biophysics, neuroscience, and engineering, General Biophysics transforms cutting-edge research into practical, scalable medical solutions. Our work bridges the gap between laboratory discovery and real-world therapeutic applications, positioning xenon gas as a powerful tool in next-generation healthcare.
What research areas does General Biophysics focus on?
General Biophysics focuses on xenon-based research in neurodegeneration, Alzheimer’s disease, opioid use disorder, and cellular preservation technologies.
How is xenon used in neurodegeneration research?
Xenon is studied for its neuroprotective and anti-inflammatory effects, particularly its ability to regulate microglial activity and slow disease progression.
Can xenon help with opioid use disorder?
Research suggests that xenon inhalation may reduce withdrawal symptoms, support opioid tapering, and provide a non-addictive treatment alternative.
What is Cellular Preservation Technology (CPT)?
CPT is an innovative approach to extending the lifespan of biological materials, such as platelets, improving their availability for therapeutic use.
Is this research clinically applied?
General Biophysics is working on translating research into practical drug-device combination therapies and scalable medical technologies.